Archive for the Category ‘Healthcare and Beauty’

Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression

Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression

Data Presented at the 165th Annual Meeting of the American Psychiatric Association in Philadelphia, Pennsylvania OSAKA, Japan – Monday, May 7th 2012 [ME NewsWire] (BUSINESS WIRE)– Dainippon Sumitomo Pharma Co., Ltd. (DSP) announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, [...]

Covidien and GE Healthcare Form Five-Year Collaboration

Covidien and GE Healthcare Form Five-Year Collaboration

Bringing Covidien measurement technologies to GE Healthcare patient monitoring helps enhance clinical decision-making BOULDER, Colo. & MILWAUKEE – Thursday, May 3rd 2012 [ME NewsWire] (BUSINESS WIRE)– Covidien(NYSE: COV) and GE Healthcare(NYSE: GE), leading global providers of healthcare products and recognized innovators in patient monitoring and respiratory care devices, today announced a five-year, global collaboration to [...]

SonoSite Establishes Ultrasound Training Program in Kenya at Great Lakes University in Collaboration with the African Institute of Innovation and Technology

SonoSite Establishes Ultrasound Training Program in Kenya at Great Lakes University in Collaboration with the African Institute of Innovation and Technology

BOTHELL, Wash. – Tuesday, May 1st 2012 [ME NewsWire] (BUSINESS WIRE)– SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, today announced a partnership with the African Institute of Innovation and Technology (AIIT), a Kenyan education trust, to establish the first ultrasound education program at Great Lakes University of Kisumu-a technology hub [...]

Mubadala’s ICLDC Receives JCI Quality Endorsement for Abu Dhabi and Al Ain

Mubadala’s ICLDC Receives JCI Quality Endorsement for Abu Dhabi and Al Ain

Only medical facility worldwide to hold both JCI Ambulatory Care and Diabetes Management “The citizens of the United Arab Emirates should be proud that Imperial College London Diabetes Centre continues to focus on this most challenging goal – to continuously raise quality to higher levels…” Ann Jacobson, JCI Abu Dhabi, UAE April 25 2012: In [...]

Cybex Wins Prestigious FIBO Innovation Award 2012

Cybex Wins Prestigious FIBO Innovation Award 2012

MEDWAY, Mass. – Tuesday, April 24th 2012 [ME NewsWire] Ground-breaking stabilization on Cybex Bravo Press and Pull combines advantages of multi-function cable systems, single-function fixed-path strength equipment; gives users more variety with faster, safer results FIBO (BUSINESS WIRE)– Cybex International, Inc. (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment, recently received the prestigious FIBO [...]

Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012

Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012

CAMBRIDGE, Mass. & NEW YORK – Monday, April 23rd 2012 [ME NewsWire] (BUSINESS WIRE)– Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) today announced that the U.S. Food and Drug Administration (FDA) notified the companies that it will require a three-month extension to complete its review of the data supporting the New [...]

70 Patient and Professional Organisations from 39 Countries Launch Global Initiative to Help Prevent Atrial Fibrillation-related Strokes

70 Patient and Professional Organisations from 39 Countries Launch Global Initiative to Help Prevent Atrial Fibrillation-related Strokes

Dubai, United Arab Emirates – Monday, April 23rd 2012 [ME NewsWire] Sign Against Stroke Campaign launched at World Heart Federation’s World Congress of Cardiology; calls for 1.7 million voices to unite to improve the care and treatment of atrial fibrillation, which increases stroke risk by 500 percent (BUSINESS WIRE)– World Heart Federation, World Congress of [...]

GLORIATM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced

GLORIATM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced

DUBAI, United Arab Emirates – Friday, April 20th 2012 [ME NewsWire] For Non-US, Non-UK & Non-Canadian Media Only (BUSINESS WIRE)– Boehringer Ingelheim announced today the launch of the GLORIATM-AF Registry Program, which is set to become the largest worldwide registry with the aim of understanding the long-term use of oral antithrombotic therapy in the prevention [...]

First Ever Data Investigating Interferon-Free Treatment in Hepatitis C Patients Who Have Liver Cirrhosis Shows High Viral Cure Rate

First Ever Data Investigating Interferon-Free Treatment in Hepatitis C Patients Who Have Liver Cirrhosis Shows High Viral Cure Rate

BARCELONA, Spain & INGELHEIM, Germany – Thursday, April 19th 2012 [ME NewsWire]   (BUSINESS WIRE)– For media outside of the U.S.A. only New data from the SOUND-C2 study shows that up to 71 percent of patients with hepatitis C and liver cirrhosis achieved a viral cure, after just 28 weeks of treatment. These patients, who [...]

Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)

Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)

BARCELONA, Spain & INGELHEIM, Germany – Thursday, April 19th 2012 [ME NewsWire] (BUSINESS WIRE)– For media outside of the U.S.A. only New data from the largest Phase II interferon-free trial to date, reveal that up to 82 percent of hepatitis C patients achieved a viral cure after just 28 weeks of treatment. These results were [...]

Advertisement

Recently Commented